Skip to content

Effect of Tara Mandura Guda in Obesity

A Randomised Comparative Clinical Trial To Evaluate The Effect Of Tara Mandura Guda And Navaka Guggulu In The Management Of Sthoulya w.s.r To Obesity - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071187
Enrollment
40
Registered
2024-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Sponsors

Dr Vidya Maishale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having classical signs and symptoms of Sthoulya. 2. Patient with BMI above 25 and below 40. 3. Both fresh and treated cases, who are not on medication for obesity atleast for 1 month. 4. Subjects willing to sign consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant and Lactating women’s. 2. Diagnosed cases of PCOD, Hypothyroidism, Diabetes mellitus and Hypertension who are on medications. 3. Any other conditions where researcher may feel it may intervein the study. 4. Patients under on going concomitant medications which may intervein the study.

Design outcomes

Primary

MeasureTime frame
Effect of Trial drug on improvement in classical symptoms of Sthoulya (Obesity)Timepoint: 15day, 30day, 60day

Secondary

MeasureTime frame
Safety of the trial drug and adverse drug reaction and aggravation in the symptoms of Sthoulya (Obesity)Timepoint: 15day, 30day, 60day

Countries

India

Contacts

Public ContactDr Vidya Maishale

Sidramappa Danigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre

vaidyasukumar@gmail.com9986125625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026